Back to top

CICC Sticks to Its Buy Rating for HUTCHMED (China) (HCM)

CICC analyst maintained a Buy rating on HUTCHMED (China) yesterday and set a price target of HK$26.00. The company’s shares opened today at HK$20.0...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HUTCHMED (China) Limited Sponsored ADR (HCM)